ProFem Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 5


  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $1.09M

  • Investors
  • 2

ProFem General Information


Operator of a pharmaceutical company intended for the clinical development of drugs for the treatment of women's diseases. The company offers new treatment options for frequently recurring and chronic infections of the lower female genital tract where infections are often associated with the formation of biofilms, enabling healthcare providers to treat gynecological diseases with high therapeutic need in women.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Corporate Office
  • Riglergasse 4
  • Vienna, 1180
  • Austria
+43 01 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProFem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - General $1.09M 00.000 Completed Generating Revenue
3. Later Stage VC 31-Mar-2018 Completed Clinical Trials - Phase 3
2. Seed Round 01-Jan-2015 Completed Startup
1. Accelerator/Incubator $35.6K Completed Startup
To view ProFem’s complete valuation and funding history, request access »

ProFem Patents

ProFem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018367116-A1 Emulsions for treating mucous membrane infections Pending 14-Nov-2017 0000000000
CA-3082727-A1 Emulsions for the topical treatment of dermal and mucosal infections Pending 14-Nov-2017 0000000000
CA-3082720-A1 Emulsions for treating mucosal infections Pending 14-Nov-2017 0000000000
AU-2018367122-A1 Emulsions for the topical treatment of dermal infections and mucosal infections Pending 14-Nov-2017 0000000000
US-11266600-B2 Emulsions for the topical treatment of dermal and mucosal infections Active 14-Nov-2017 A61K9/0014 00
To view ProFem’s complete patent history, request access »

ProFem Executive Team (5)

Name Title Board Seat Contact Info
Marion Noe-Letschnig Co-Founder, Managing Director & Chief Executive Officer
Karin Vilsmeier-Dietrich Chief Financial Officer & Partner
Peter Swely Co-Founder & Board Member
Christian Noe Co-Founder, Board Member & CSO
Ghazaleh Lechner MD Chief Medical Officer & Partner
To view ProFem’s complete executive team members history, request access »

ProFem Board Members (4)

Name Representing Role Since
Andrew Jank Self Board Member 000 0000
Christian Noe ProFem Co-Founder, Board Member & CSO 000 0000
Peter Swely ProFem Co-Founder & Board Member 000 0000
Wolfgang Vilsmeier Self Board Member 000 0000
To view ProFem’s complete board members history, request access »

ProFem Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProFem Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Austria Wirtschaftsservice Venture Capital Minority 000 0000 000000 0
INiTS Universitäres Gründerservice Accelerator/Incubator Minority 000 0000 000000 0
To view ProFem’s complete investors history, request access »

ProFem FAQs

  • When was ProFem founded?

    ProFem was founded in 2012.

  • Who is the founder of ProFem?

    Marion Noe-Letschnig, Peter Swely, and Christian Noe are the founders of ProFem.

  • Who is the CEO of ProFem?

    Marion Noe-Letschnig is the CEO of ProFem.

  • Where is ProFem headquartered?

    ProFem is headquartered in Vienna, Austria.

  • What is the size of ProFem?

    ProFem has 5 total employees.

  • What industry is ProFem in?

    ProFem’s primary industry is Drug Discovery.

  • Is ProFem a private or public company?

    ProFem is a Private company.

  • What is ProFem’s current revenue?

    The current revenue for ProFem is 00000.

  • How much funding has ProFem raised over time?

    ProFem has raised $1.09M.

  • Who are ProFem’s investors?

    Austria Wirtschaftsservice and INiTS Universitäres Gründerservice have invested in ProFem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »